Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$535M |
| 2 |
Meta Platforms (Facebook)
META
|
+$388M |
| 3 |
SLB Ltd
SLB
|
+$348M |
| 4 |
Visa
V
|
+$230M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$203M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Danaher
DHR
|
+$350M |
| 2 |
Chevron
CVX
|
+$349M |
| 3 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$337M |
| 4 |
Dell
DELL
|
+$332M |
| 5 |
SODA
SodaStream International Ltd
SODA
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.48% |
| 2 | Technology | 13.21% |
| 3 | Financials | 10.74% |
| 4 | Real Estate | 9.97% |
| 5 | Utilities | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STRM
3051
DELISTED
Streamline Health Solutions
STRM
| $274K | ﹤0.01% |
22,570
-57
| -0.3% | -$771 |
|
|
MMAC
3052
DELISTED
MMA Capital Holdings, Inc. Common Stock
MMAC
| $274K | ﹤0.01% |
10,888
-5,390
| -33% | -$141K |
|
3053
ProShares UltraShort Dow 30
DXD
$42.6M
| $273K | ﹤0.01% |
+1,545
| New | +$247K |
|
3054
Gray Media Inc
GTN.A
$699M
| $273K | ﹤0.01% |
20,600
+700
| +4% | +$11.1K |
|
|
NOTV
3055
DELISTED
Inotiv
NOTV
| $273K | ﹤0.01% |
215,281
-30,169
| -12% | -$42.3K |
|
|
ORKA
3056
Oruka Therapeutics
ORKA
$5.9B
| $273K | ﹤0.01% |
3,790
+686
| +22% | +$85.1K |
|
3057
Scully Royalty
SRL
$76.9M
| $270K | ﹤0.01% |
51,870
-15,700
| -23% | -$78K |
|
|
MDLY
3058
DELISTED
Medley Management Inc
MDLY
| $270K | ﹤0.01% |
7,000
+3,060
| +78% | +$153K |
|
3059
Anterix
ATEX
$1.82B
| $269K | ﹤0.01% |
7,200
+1,200
| +20% | +$46.9K |
|
|
MYND
3060
Mynd.ai
MYND
$18.2M
| $269K | ﹤0.01% |
+4,600
| New | +$596K |
|
3061
Green Plains
GPRE
$1.21B
| $267K | ﹤0.01% |
+20,400
| New | +$334K |
|
|
MESO
3062
Mesoblast
MESO
$1.89B
| $267K | ﹤0.01% |
32,400
-50,181
| -61% | -$575K |
|
|
NTRP
3063
DELISTED
Neurotrope, Inc. Common
NTRP
| $267K | ﹤0.01% |
74,747
+24,747
| +49% | +$150K |
|
3064
ClearOne Inc
CLRO
$11.5M
| $266K | ﹤0.01% |
14,185
+2,080
| +17% | +$46.3K |
|
3065
Ingersoll Rand
IR
$33B
| $266K | ﹤0.01% |
+13,000
| New | +$319K |
|
3066
WidePoint Corp
WYY
$97M
| $266K | ﹤0.01% |
63,756
+5,680
| +10% | +$27K |
|
|
UFAB
3067
DELISTED
Unique Fabricating, Inc.
UFAB
| $265K | ﹤0.01% |
62,896
-13,900
| -18% | -$90.1K |
|
|
BNSO
3068
DELISTED
Bonso Electronic International
BNSO
| $265K | ﹤0.01% |
131,700
+300
| +0.2% | +$746 |
|
|
BSCK
3069
DELISTED
Invesco BulletShares 2020 Corporate Bond ETF
BSCK
| $265K | ﹤0.01% |
12,593
-40,907
| -76% | -$860K |
|
|
MBAI
3070
Check-Cap
MBAI
$8.27M
| $264K | ﹤0.01% |
6,142
-265
| -4% | -$17.8K |
|
3071
Spero Therapeutics
SPRO
$69.5M
| $264K | ﹤0.01% |
42,903
+30,903
| +258% | +$250K |
|
3072
Invesco S&P SmallCap Low Volatility ETF
XSLV
$247M
| $264K | ﹤0.01% |
+6,200
| New | +$286K |
|
3073
Lipocine
LPCN
$17.4M
| $262K | ﹤0.01% |
11,859
+3,906
| +49% | +$90.6K |
|
|
ENFY
3074
DELISTED
Enlightify Inc
ENFY
| $262K | ﹤0.01% |
43,667
-1,751
| -4% | -$13.3K |
|
3075
iShares US Oil Equipment & Services ETF
IEZ
$353M
| $259K | ﹤0.01% |
+12,700
| New | +$358K |
|
Similar funds
Renaissance Technologies's Q4 2018 Portfolio in Review
As of Q4 2018, Renaissance Technologies held 3,847 positions worth $91.3B, down 6.1% from $97.3B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Renaissance Technologies deployed $8.84B of net new capital in Q4 2018, opening 522 new positions and adding to 1,588 existing holdings. Its largest new stake was Apple: 11,041,936 shares worth $435M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 18% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Dell, an estimated $332M trimmed.
- Renaissance Technologies's largest Q4 2018 buy was Apple: 11,041,936 shares worth $435M.
- Renaissance Technologies added most to Meta Platforms (Facebook) in Q4 2018, an estimated $388M increase.
- Renaissance Technologies's biggest Q4 2018 reduction was Dell, cutting an estimated $332M.
- Renaissance Technologies fully exited Danaher in Q4 2018, selling an estimated $350M.
- Renaissance Technologies's ten largest holdings make up 9.1% of its $91.3B portfolio in Q4 2018.
- Renaissance Technologies opened 522 new positions and closed 504 in Q4 2018.
- Renaissance Technologies's portfolio value fell 6.1% quarter-over-quarter to $91.3B.
Based on Renaissance Technologies's 13F filing for Q4 2018, filed 13 Feb 2019.